An international simulated-use study to assess nurses' preferences between two lanreotide syringes for patients with neuroendocrine tumours or acromegaly (PRESTO 3)

Ferone, D; Martin, W; Williams, J; Houchard, A; Pommie, C; Ribeiro-Oliveira, A; Grossman, AB

Grossman, AB (通讯作者),Univ Oxford, Green Templeton Coll, Oxford, England.;Grossman, AB (通讯作者),Royal Free Hosp, ENETS Ctr Excellence, Neuroendocrine Tumour Unit, London, England.;Grossman, AB (通讯作者),Barts & London Queen Marys Sch Med & Dent, Ctr Endocrinol, London, England.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023; ():

Abstract

Purpose PRESTO 3 evaluated nurses' preference for the Somatuline (R) Autogel (R) syringe versus the Lanreotide Pharmathen syringe after injection-pad ......

Full Text Link